Search by Drug Name or NDC
NDC 68382-0775-10 Methotrexate 2.5 mg/1 Details
Methotrexate 2.5 mg/1
Methotrexate is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals USA Inc.. The primary component is METHOTREXATE.
MedlinePlus Drug Summary
Methotrexate is used to treat severe psoriasis (a skin disease in which red, scaly patches form on some areas of the body) that cannot be controlled by other treatments. Methotrexate is also used along with rest, physical therapy, and sometimes other medications to treat severe active rheumatoid arthritis (RA; a condition in which the body attacks its own joints, causing pain, swelling, and loss of function) that cannot be controlled by certain other medications. Methotrexate is also used to treat certain types of cancer including cancers that begin in the tissues that form around a fertilized egg in the uterus, breast cancer, lung cancer, certain cancers of the head and neck, certain types of lymphoma, and leukemia (cancer that begins in the white blood cells). Methotrexate is in a class of medications called antimetabolites. Methotrexate treats cancer by slowing the growth of cancer cells. Methotrexate treats psoriasis by slowing the growth of skin cells to stop scales from forming. Methotrexate may treat rheumatoid arthritis by decreasing the activity of the immune system.
Related Packages: 68382-0775-10Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Methotrexate
Product Information
NDC | 68382-0775 |
---|---|
Product ID | 68382-775_12e61f0c-901b-4891-9a52-0cf78ebe64b6 |
Associated GPIs | 21300050100310 |
GCN Sequence Number | 036872 |
GCN Sequence Number Description | methotrexate sodium TABLET 2.5 MG ORAL |
HIC3 | V1B |
HIC3 Description | ANTINEOPLASTIC - ANTIMETABOLITES |
GCN | 38489 |
HICL Sequence Number | 003905 |
HICL Sequence Number Description | METHOTREXATE SODIUM |
Brand/Generic | Generic |
Proprietary Name | Methotrexate |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Methotrexate |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | TABLET |
Route | ORAL |
Active Ingredient Strength | 2.5 |
Active Ingredient Units | mg/1 |
Substance Name | METHOTREXATE |
Labeler Name | Zydus Pharmaceuticals USA Inc. |
Pharmaceutical Class | Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA207812 |
Listing Certified Through | 2024-12-31 |
Package
NDC 68382-0775-10 (68382077510)
NDC Package Code | 68382-775-10 |
---|---|
Billing NDC | 68382077510 |
Package | 1000 TABLET in 1 BOTTLE (68382-775-10) |
Marketing Start Date | 2017-02-09 |
NDC Exclude Flag | N |
Pricing Information | N/A |